Constitutive Expression of the Cyclin-dependent Kinase Inhibitor p21 Is Transcriptionally Regulated by the Tumor Suppressor Protein p53
Open Access
- 1 November 1998
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 273 (44) , 29156-29163
- https://doi.org/10.1074/jbc.273.44.29156
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Protein interactions at the carboxyl terminus of p53 result in the induction of its in vitro transactivation potentialOncogene, 1997
- Regulation of p53 stability by Mdm2Nature, 1997
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- Regulation of Mutant p53 Temperature-sensitive DNA BindingPublished by Elsevier ,1996
- Two Distinct Signaling Pathways Activate the Latent DNA Binding Function of p53 in a Casein Kinase II-independent MannerPublished by Elsevier ,1995
- p21 is a universal inhibitor of cyclin kinasesNature, 1993
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53Nature, 1993
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992
- Distribution of LH-RH in subcellular fractions of the basomedial hypothalamusMolecular and Cellular Endocrinology, 1975